Azafaros

Olivier Morand, CEO
Olivier Morand, CEO
Netherlands | Funding: $27.5M (+)

Website: https://www.azafaros.com/

Azafaros B.V. aims at developing new therapeutic agents for the treatment of rare metabolic disorders.